Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Нестероидные противовоспалительные препараты в терапии боли в спине: оценка пользы и рисков
Нестероидные противовоспалительные препараты в терапии боли в спине: оценка пользы и рисков
О.В.Воробьева. Нестероидные противовоспалительные препараты в терапии боли в спине: оценка пользы и рисков. Справочник поликлинического врача. 2016; 4: 22–26.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Moore RA, Derry S, Simon LS, Emery P. Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk. Pain Pract 2014; 14: 378–95.
2. Boonstraa AM, Schiphorst Preuperb HR, Balka GA, Stewart RE. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain 2014; 155 (12): 2545–50.
3. Barden J, Derry S, McQuay H, Moore R. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 2009; 4: CD007355.
4. Piccoliori G, Engl A, Gatterer D et al. Management of low back pain in general practice – is it of acceptable quality: an observational study among 25 general practices in South Tyrol (Italy). BMC Family Pract 2013, 14: 148.
5. Machado GC, Maher CG, Ferreira PH. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225.
6. Innes G, Croskerry P, Worthington J et al. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med 1998; 16 (4): 549–56.
7. Harris RC, Breyer MD. Update on Cyclooxygenase-2 Inhibitors. Clin J Am Soc Nephrol 2006; 1 (2): 236–45. Epub 2006 Feb 1.
8. Cheng HF, Harris RC. Cyclooxygenases, the kidney, and hypertension. Hypertension. 2004; 43 (3): 525–30. Epub 2004 Jan 19.
9. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenes an opportunities. J Clin Invest 2006; 116 (1): 4–15.
10. Schaeverbeke T, Heloire F, Deray G. How to watch over a patient treated with a NSAID in relation to the cardiovascular and renal risk? Presse Med 2006; 35 (Suppl. 1): 41–6.
11. Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 2013; 15 (Suppl. 3): S3. doi: 10.1186/ar4175. Epub 2013 Jul 24.
12. Fries JF, Murtagh KN, Bennett M et al. The rise and decline of nonsteroidal anti-inflammatory drag-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004; 50 (8): 2433–40.
13. Lewis JD, Kimmel SE, Localio AR. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005; 129: 1865–74.
14. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Совр. ревматология. 2015; 1: 4–23.
15. Colberg K, Hettich M, Sigmand R et al. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. Curr Med Res Opin 1996; 13: 363–77.
16. Roelofs PD, Deyo RA, Koes BW et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008; 1: CD000396.
17. Батышева Т.Т., Отческая О.В., Хозова А.А. и др. Эффективность применения комбинации препаратов артрозан и комбилипен у пациентов с болью в нижней части спины. Журн. неврологии и психиатрии. 2011; 9 (2): 41–4.
2. Boonstraa AM, Schiphorst Preuperb HR, Balka GA, Stewart RE. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain 2014; 155 (12): 2545–50.
3. Barden J, Derry S, McQuay H, Moore R. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 2009; 4: CD007355.
4. Piccoliori G, Engl A, Gatterer D et al. Management of low back pain in general practice – is it of acceptable quality: an observational study among 25 general practices in South Tyrol (Italy). BMC Family Pract 2013, 14: 148.
5. Machado GC, Maher CG, Ferreira PH. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 2015; 350: h1225.
6. Innes G, Croskerry P, Worthington J et al. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med 1998; 16 (4): 549–56.
7. Harris RC, Breyer MD. Update on Cyclooxygenase-2 Inhibitors. Clin J Am Soc Nephrol 2006; 1 (2): 236–45. Epub 2006 Feb 1.
8. Cheng HF, Harris RC. Cyclooxygenases, the kidney, and hypertension. Hypertension. 2004; 43 (3): 525–30. Epub 2004 Jan 19.
9. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenes an opportunities. J Clin Invest 2006; 116 (1): 4–15.
10. Schaeverbeke T, Heloire F, Deray G. How to watch over a patient treated with a NSAID in relation to the cardiovascular and renal risk? Presse Med 2006; 35 (Suppl. 1): 41–6.
11. Sostres C, Gargallo CJ, Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 2013; 15 (Suppl. 3): S3. doi: 10.1186/ar4175. Epub 2013 Jul 24.
12. Fries JF, Murtagh KN, Bennett M et al. The rise and decline of nonsteroidal anti-inflammatory drag-associated gastropathy in rheumatoid arthritis. Arthritis Rheum 2004; 50 (8): 2433–40.
13. Lewis JD, Kimmel SE, Localio AR. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005; 129: 1865–74.
14. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Совр. ревматология. 2015; 1: 4–23.
15. Colberg K, Hettich M, Sigmand R et al. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. Curr Med Res Opin 1996; 13: 363–77.
16. Roelofs PD, Deyo RA, Koes BW et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008; 1: CD000396.
17. Батышева Т.Т., Отческая О.В., Хозова А.А. и др. Эффективность применения комбинации препаратов артрозан и комбилипен у пациентов с болью в нижней части спины. Журн. неврологии и психиатрии. 2011; 9 (2): 41–4.
Авторы
О.В.Воробьева
ФГБОУ ВО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России
ФГБОУ ВО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.